title: [Small bowel transplantation: Report of a single case].
abstract: Small bowel transplantation is associated with a patient survival at one and five years, of 80% and 63%, respectively. We report a 36 year-old female with short bowel syndrome, subjected to the first small bowel transplantation performed in Chile. A cadaveric gran was used. Immunosuppression was achieved by means of alemtuzumab, tacrolimus, sirolimus, micofenolate mofetil and steroids. Serial endoscopies and biopsies were performed during seven months after transplantation. The most important late complications were a drug induced renal failure, infections caused by opportunistic agents and a gastrointestinal bleeding probably induced by drugs. After 29 months of follow up, the patient is ambulatory, on oral diet only and with no evidence of graft rejection.
authors: Unidad de Gastroenterología, Clínica Las Condes. ebuckel@clinicalascondes.cl
authors: Erwin
authors: E
authors: Buckel G
authors: Mario
authors: M
authors: Ferrario B
authors: Mario
authors: M
authors: Uribe M
authors: Gloria
authors: G
authors: González G
authors: Jorge
authors: J
authors: Godoy L
authors: Fernando
authors: F
authors: Fluxá G
authors: Rodrigo
authors: R
authors: Quera P
authors: Verner
authors: V
authors: Codoceo R
authors: Jorge
authors: J
authors: Morales B
authors: David
authors: D
authors: Benavente M
authors: María Teresa
authors: MT
authors: Santander D
authors: Cristina
authors: C
authors: Herzog O
mesh_terms: D000328:Adult; D002677:Chile; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007421:Intestine, Small / Q000637:transplantation*; D012778:Short Bowel Syndrome / Q000276:immunology / Q000601:surgery*; D016559:Tacrolimus / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus